VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
VSCOX
Price
$31.32
Change
-$0.06 (-0.19%)
Updated
Jul 31 closing price
Net Assets
1.64B
Interact to see
Advertisement

VSCIX vs VSCOX

VSCIX vs VSCOX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. VSCOX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and VSCOX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. VSCOX (1.64B). VSCIX pays higher dividends than VSCOX: VSCIX (1.23) vs VSCOX (0.47). VSCIX was incepted earlier than VSCOX: VSCIX (29 years) vs VSCOX (29 years). VSCOX (1.26) is less costly to investors than VSCIX (0.03). VSCOX is a more actively managed with annual turnover of: 49.00 vs. VSCIX (17.00). VSCOX has a lower initial minimum investment than VSCIX: VSCOX (1000) vs VSCIX (5000000). VSCIX (22.58) and VSCOX (21.64) have marching annual gain over last year. VSCIX return over 5 years is better than : 35.13 vs. VSCOX (13.35).
VSCIXVSCOXVSCIX / VSCOX
Total Expense Ratio0.031.242%
Annual Report Gross Expense Ratio0.031.262%
Fund Existence29 years29 years-
Gain YTD14.59120.46271%
Front LoadN/A5%-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets189B1.64B11,538%
Annual Yield % from dividends1.230.47259%
Returns for 1 year22.5821.64104%
Returns for 3 years43.4432.63133%
Returns for 5 years35.1313.35263%
Returns for 10 years156.0755.31282%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C